📣 VC round data is live. Check it out!
- Public Comps
- SOPHiA Genetics
SOPHiA Genetics Valuation Multiples
Discover SOPHiA Genetics' revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Prenetics Global, TaiDoc Technology, ToolGen, Medical Data Vision and more.
SOPHiA Genetics Overview
About SOPHiA Genetics
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
Founded
2011
HQ

Employees
423
Website
Financials (LTM)
EV
$348M
Valuation Multiples
Start free trialSOPHiA Genetics Financials
SOPHiA Genetics reported last 12-month revenue of $84M and negative EBITDA of ($38M).
In the same LTM period, SOPHiA Genetics generated $57M in gross profit, ($38M) in EBITDA losses, and had net loss of ($73M).
Revenue (LTM)
SOPHiA Genetics P&L
In the most recent fiscal year, SOPHiA Genetics reported revenue of $77M and EBITDA of ($42M).
SOPHiA Genetics is unprofitable as of last fiscal year, with gross margin of 67%, EBITDA margin of (54%), and net margin of (102%).
Financial data powered by Morningstar, Inc.
SOPHiA Genetics Stock Performance
SOPHiA Genetics has current market cap of $351M, and enterprise value of $348M.
Market Cap Evolution
SOPHiA Genetics' stock price is $4.89.
SOPHiA Genetics share price decreased by 3.4% in the last 30 days, and increased by 57.7% in the last year.
SOPHiA Genetics has an EPS (earnings per share) of $-1.10.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $348M | $351M | -2.0% | -3.4% | -1.2% | 57.7% | $-1.10 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSOPHiA Genetics Valuation Multiples
SOPHiA Genetics trades at 4.1x EV/Revenue multiple, and (9.2x) EV/EBITDA.
EV / Revenue (LTM)
SOPHiA Genetics Financial Valuation Multiples
As of June 3, 2026, SOPHiA Genetics has market cap of $351M and EV of $348M.
SOPHiA Genetics has a P/E ratio of (4.8x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified SOPHiA Genetics Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


SOPHiA Genetics Margins & Growth Rates
SOPHiA Genetics grew revenue by 21% but EBITDA decreased by 21% in the last fiscal year.
In the most recent fiscal year, SOPHiA Genetics reported gross margin of 67%, EBITDA margin of (54%), and net margin of (102%).
SOPHiA Genetics Margins
SOPHiA Genetics Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
SOPHiA Genetics Operational KPIs
SOPHiA Genetics' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.3M for the same period.
SOPHiA Genetics' Rule of 40 is (14%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
SOPHiA Genetics' Rule of X is 17% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
SOPHiA Genetics Competitors
SOPHiA Genetics competitors include Prenetics Global, TaiDoc Technology, ToolGen, Medical Data Vision, Cogstate, CareNet, Myriad Genetics, Abclon, Evolent Health and Atrys Health.
Most SOPHiA Genetics public comparables operate across Health Data & Analytics, Diagnostics & Genomics, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 3.2x | 2.1x | (22.5x) | (19.0x) | |||
| 1.8x | - | 4.1x | - | |||
| 347.6x | - | (13.4x) | - | |||
| - | 9.2x | - | - | |||
| 5.0x | 4.5x | 15.8x | 15.3x | |||
| - | - | - | - | |||
| 0.6x | 0.6x | 12.7x | 12.8x | |||
| 130.0x | - | (37.5x) | - | |||
This data is available for Pro users. Sign up to see all SOPHiA Genetics competitors and their valuation data. Start Free Trial | ||||||
SOPHiA Genetics VC Funding History
Before going public, SOPHiA Genetics raised $250M in total equity funding, across 6 rounds.
Last private valuation of SOPHiA Genetics was $586M, after raising $110M in October 2020 from aMoon Fund, Credit Suisse Asset Mgmt, Endeavour Vision, and 7 other investors.
SOPHiA Genetics Funding Rounds
Acquisitions by SOPHiA Genetics
SOPHiA Genetics has acquired 1 company to date.
Last acquisition by SOPHiA Genetics was on June 17th 2018. SOPHiA Genetics acquired Interactive Biosoftware for undisclosed valuation.
Latest Acquisitions by SOPHiA Genetics
| Description | Interactive Biosoftware is a Rouen, France-headquartered developer of software for genetic analysis in healthcare and life sciences, particularly molecular biology. Founded in April 2007 by medical and computer scientists, the company provides tools for geneticists to perform variant annotation, surveillance, and data sharing across genome research tiers. Its Alamut Batch engine, launched in 2012, excels in high-throughput analysis with detailed RNA splicing data. |
| HQ Country | |
| HQ City | Rouen |
| Deal Date | 17 Jun 2018 |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all SOPHiA Genetics acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout SOPHiA Genetics
| When was SOPHiA Genetics founded? | SOPHiA Genetics was founded in 2011. |
| Where is SOPHiA Genetics headquartered? | SOPHiA Genetics is headquartered in France. |
| How many employees does SOPHiA Genetics have? | As of today, SOPHiA Genetics has over 423 employees. |
| Who is the CEO of SOPHiA Genetics? | SOPHiA Genetics' CEO is Jurgi Camblong. |
| Is SOPHiA Genetics publicly listed? | Yes, SOPHiA Genetics is a public company listed on Nasdaq. |
| What is the stock symbol of SOPHiA Genetics? | SOPHiA Genetics trades under SOPH ticker. |
| When did SOPHiA Genetics go public? | SOPHiA Genetics went public in 2021. |
| Who are competitors of SOPHiA Genetics? | SOPHiA Genetics main competitors include Prenetics Global, TaiDoc Technology, ToolGen, Medical Data Vision, Cogstate, CareNet, Myriad Genetics, Abclon, Evolent Health, Atrys Health. |
| What is the current market cap of SOPHiA Genetics? | SOPHiA Genetics' current market cap is $351M. |
| What is the current revenue of SOPHiA Genetics? | SOPHiA Genetics' last 12 months revenue is $84M. |
| What is the current revenue growth of SOPHiA Genetics? | SOPHiA Genetics revenue growth (NTM/LTM) is 21%. |
| What is the current EV/Revenue multiple of SOPHiA Genetics? | Current revenue multiple of SOPHiA Genetics is 4.1x. |
| Is SOPHiA Genetics profitable? | No, SOPHiA Genetics is not profitable. |
| What is the current EBITDA of SOPHiA Genetics? | SOPHiA Genetics has negative EBITDA and is not profitable. |
| What is SOPHiA Genetics' EBITDA margin? | SOPHiA Genetics' last 12 months EBITDA margin is (45%). |
| What is the current EV/EBITDA multiple of SOPHiA Genetics? | Current EBITDA multiple of SOPHiA Genetics is (9.2x). |
| How many companies SOPHiA Genetics has acquired to date? | As of June 2026, SOPHiA Genetics has acquired 1 company. |
| What was the largest acquisition by SOPHiA Genetics? | None of the M&A deals SOPHiA Genetics has completed have disclosed valuations. |
| What companies SOPHiA Genetics acquired? | SOPHiA Genetics acquired Interactive Biosoftware. |
| In how many companies SOPHiA Genetics has invested to date? | SOPHiA Genetics hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to SOPHiA Genetics
Lists including SOPHiA Genetics
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
